-
Je něco špatně v tomto záznamu ?
Genotype-phenotype correlation in 44 Czech, Slovak, Croatian and Serbian patients with mucopolysaccharidosis type II
L. Dvorakova, H. Vlaskova, A. Sarajlija, DP. Ramadza, H. Poupetova, E. Hruba, A. Hlavata, V. Bzduch, K. Peskova, G. Storkanova, B. Kecman, M. Djordjevic, I. Baric, K. Fumic, I. Barisic, M. Reboun, J. Kulhanek, J. Zeman, M. Magner,
Jazyk angličtina Země Dánsko
Typ dokumentu časopisecké články
PubMed
27883178
DOI
10.1111/cge.12927
Knihovny.cz E-zdroje
- MeSH
- dítě MeSH
- dospělí MeSH
- genetické asociační studie MeSH
- glykoproteiny genetika MeSH
- glykosaminoglykany moč MeSH
- kojenec MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mukopolysacharidóza II etiologie genetika MeSH
- mutace * MeSH
- předškolní dítě MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- kojenec MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Česká republika MeSH
- Chorvatsko MeSH
- Slovenská republika MeSH
- Srbsko MeSH
Mucopolysaccharidosis type II (Hunter syndrome, MPS II, OMIM 309900) is an X-linked lysosomal storage disorder caused by deficiency of iduronate-2-sulfatase (IDS). We analyzed clinical and laboratory data from 44 Slavic patients with this disease. In total, 21 Czech, 7 Slovak, 9 Croatian and 7 Serbian patients (43 M/1 F) were included in the study (median age 11.0 years, range 1.2-43 years). Birth prevalence ranged from 1:69,223 (Serbia) to 1:192,626 (Czech Rep.). In the majority of patients (71%), the disease manifested in infancy. Cognitive functions were normal in 10 patients. Four, six and 24 patients had mild, moderate, and severe developmental delay, respectively, typically subsequent to developmental regression (59%). Residual enzyme activity showed no predictive value, and estimation of glycosaminoglycans (GAGs) had only limited importance for prognosis. Mutation analysis performed in 36 families led to the identification of 12 novel mutations, eight of which were small deletions/insertions. Large deletions/rearrangements and all but one small deletion/insertion led to a severe phenotype. This genotype-phenotype correlation was also identified in six cases with recurrent missense mutations. Based on patient genotype, the severity of the disease may be predicted with high probability in approximately half of MPS II patients.
Department of Paediatrics Children's Hospital Zagreb School of Medicine Zagreb Croatia
Department of Pediatrics University Hospital Center Zagreb Croatia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17023481
- 003
- CZ-PrNML
- 005
- 20170830115730.0
- 007
- ta
- 008
- 170720s2017 dk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/cge.12927 $2 doi
- 035 __
- $a (PubMed)27883178
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a dk
- 100 1_
- $a Dvorakova, L $u Institute of Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 245 10
- $a Genotype-phenotype correlation in 44 Czech, Slovak, Croatian and Serbian patients with mucopolysaccharidosis type II / $c L. Dvorakova, H. Vlaskova, A. Sarajlija, DP. Ramadza, H. Poupetova, E. Hruba, A. Hlavata, V. Bzduch, K. Peskova, G. Storkanova, B. Kecman, M. Djordjevic, I. Baric, K. Fumic, I. Barisic, M. Reboun, J. Kulhanek, J. Zeman, M. Magner,
- 520 9_
- $a Mucopolysaccharidosis type II (Hunter syndrome, MPS II, OMIM 309900) is an X-linked lysosomal storage disorder caused by deficiency of iduronate-2-sulfatase (IDS). We analyzed clinical and laboratory data from 44 Slavic patients with this disease. In total, 21 Czech, 7 Slovak, 9 Croatian and 7 Serbian patients (43 M/1 F) were included in the study (median age 11.0 years, range 1.2-43 years). Birth prevalence ranged from 1:69,223 (Serbia) to 1:192,626 (Czech Rep.). In the majority of patients (71%), the disease manifested in infancy. Cognitive functions were normal in 10 patients. Four, six and 24 patients had mild, moderate, and severe developmental delay, respectively, typically subsequent to developmental regression (59%). Residual enzyme activity showed no predictive value, and estimation of glycosaminoglycans (GAGs) had only limited importance for prognosis. Mutation analysis performed in 36 families led to the identification of 12 novel mutations, eight of which were small deletions/insertions. Large deletions/rearrangements and all but one small deletion/insertion led to a severe phenotype. This genotype-phenotype correlation was also identified in six cases with recurrent missense mutations. Based on patient genotype, the severity of the disease may be predicted with high probability in approximately half of MPS II patients.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a Chorvatsko $7 D017523
- 650 _2
- $a Česká republika $7 D018153
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a genetické asociační studie $7 D056726
- 650 _2
- $a glykoproteiny $x genetika $7 D006023
- 650 _2
- $a glykosaminoglykany $x moč $7 D006025
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kojenec $7 D007223
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a mukopolysacharidóza II $x etiologie $x genetika $7 D016532
- 650 12
- $a mutace $7 D009154
- 650 _2
- $a Srbsko $7 D055771
- 650 _2
- $a Slovenská republika $7 D018154
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Vlaskova, H $u Institute of Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Sarajlija, A $u Department of Metabolism and Clinical Genetics, Mother and Child Health Care Institute of Serbia, Belgrade, Serbia. School of Medicine, University of Belgrade, Belgrade, Serbia.
- 700 1_
- $a Ramadza, D P $u Department of Pediatrics, University Hospital Center, Zagreb, Croatia.
- 700 1_
- $a Poupetova, H $u Institute of Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Hruba, E $u Institute of Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Hlavata, A $u 2nd Department of Pediatrics, Comenius University Medical School in Bratislava University Children's Hospital, Bratislava, Slovakia.
- 700 1_
- $a Bzduch, V $u 1st Department of Pediatrics, Comenius University Medical School in Bratislava University Children's Hospital, Bratislava, Slovakia.
- 700 1_
- $a Peskova, K $u Institute of Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Storkanova, G $u Institute of Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Kecman, B $u Department of Metabolism and Clinical Genetics, Mother and Child Health Care Institute of Serbia, Belgrade, Serbia.
- 700 1_
- $a Djordjevic, M $u Department of Metabolism and Clinical Genetics, Mother and Child Health Care Institute of Serbia, Belgrade, Serbia. School of Medicine, University of Belgrade, Belgrade, Serbia.
- 700 1_
- $a Baric, I $u Department of Pediatrics, University Hospital Center and University of Zagreb, School of Medicine, Zagreb, Croatia.
- 700 1_
- $a Fumic, K $u Department of Laboratory Diagnostics, University Hospital Centre Zagreb and School of Medicine, Zagreb, Croatia.
- 700 1_
- $a Barisic, I $u Department of Paediatrics, Children's Hospital Zagreb, School of Medicine, Zagreb, Croatia.
- 700 1_
- $a Reboun, M $u Institute of Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Kulhanek, J $u Department of Paediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Zeman, J $u Institute of Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic. Department of Paediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Magner, M $u Department of Paediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 773 0_
- $w MED00001127 $t Clinical genetics $x 1399-0004 $g Roč. 91, č. 5 (2017), s. 787-796
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27883178 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170720 $b ABA008
- 991 __
- $a 20170830120319 $b ABA008
- 999 __
- $a ok $b bmc $g 1239162 $s 984394
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 91 $c 5 $d 787-796 $e 20170317 $i 1399-0004 $m Clinical genetics $n Clin Genet $x MED00001127
- LZP __
- $a Pubmed-20170720